Floatz logo

Therapeutic Asset Ratings

152 results matching 1 filter

128,359 assets · 8,667 sponsors · 3,127 indications
Methodology v0.2
AssetSponsorPhaseRating
Atezolizumab
Metastatic Renal Pelvis Urothelial Carcinoma
Alliance for Clinical Trials in OncologyP3B (62)
Atezolizumab
Metastatic Ureter Urothelial Carcinoma
Alliance for Clinical Trials in OncologyP3B (62)
Denosumab
neoplasm
Alliance for Clinical Trials in OncologyP4B (60)
Arimidex
lobular breast carcinoma in situ
Alliance for Clinical Trials in OncologyP3B (60)
Arimidex
invasive ductal breast carcinoma
Alliance for Clinical Trials in OncologyP3B (60)
Arimidex
invasive lobular breast carcinoma
Alliance for Clinical Trials in OncologyP3B (60)
Cyclophosphamide
Stage III Renal Pelvis Cancer AJCC v8
Alliance for Clinical Trials in OncologyP3B (60)
Cyclophosphamide
Stage II Renal Pelvis Cancer AJCC v8
Alliance for Clinical Trials in OncologyP3B (60)
Durvalumab
renal pelvis urothelial carcinoma
Alliance for Clinical Trials in OncologyP3B (60)
Durvalumab
ureter transitional cell carcinoma
Alliance for Clinical Trials in OncologyP3B (60)
Durvalumab
urethra transitional cell carcinoma
Alliance for Clinical Trials in OncologyP3B (60)
Epirubicin
Stage III Renal Pelvis Cancer AJCC v8
Alliance for Clinical Trials in OncologyP3B (60)
Epirubicin
Stage II Renal Pelvis Cancer AJCC v8
Alliance for Clinical Trials in OncologyP3B (60)
EXEMESTANE
lobular breast carcinoma in situ
Alliance for Clinical Trials in OncologyP3B (60)
MEGESTROL ACETATE IMPURITY B
hematopoietic and lymphoid cell neoplasm
Alliance for Clinical Trials in OncologyP3B (60)
Metformin
breast intraductal proliferative lesion
Alliance for Clinical Trials in OncologyP3B (60)
Metformin
hereditary breast ovarian cancer syndrome
Alliance for Clinical Trials in OncologyP3B (60)
Metformin
BRCA2-related cancer predisposition
Alliance for Clinical Trials in OncologyP3B (60)
Metformin
lobular breast carcinoma in situ
Alliance for Clinical Trials in OncologyP3B (60)
Olanzapine
Anorexia
Alliance for Clinical Trials in OncologyP3B (60)
Pembrolizumab
Stage III Renal Pelvis Cancer AJCC v8
Alliance for Clinical Trials in OncologyP3B (60)
Pembrolizumab
renal pelvis carcinoma
Alliance for Clinical Trials in OncologyP3B (60)
Trastuzumab Emtansine
synchronous bilateral breast carcinoma
Alliance for Clinical Trials in OncologyP3B (60)
Tucatinib
synchronous bilateral breast carcinoma
Alliance for Clinical Trials in OncologyP3B (60)
Vorasidenib
astrocytoma, IDH-mutant, grade 3
Alliance for Clinical Trials in OncologyP3B (60)
Showing 51 to 75 of 152 assets
PreviousPage 3 of 7Next